Illumina is expanding the power of genomics into community cancer care—maximizing therapeutic options for more patients
Sandra Pérez’s cancer is in remission thanks to genomic sequencing and a bone marrow transplant from a newly discovered sister
At the Undiagnosed Hackathon 2025, families received access to rare disease experts, whole-genome sequencing, AI tools, and more
Illumina celebrates local partnerships and showcases its end-to-end multiomics solutions at CIIE
The company has proven its ability to decode the unknown regions of the genome
| Date | Publication | Title |
|---|---|---|
| 23 Jun. 2025 | Endpoints News | Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics |
| 17 Jun. 2025 | Forbes | Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics |
| 13 Jun. 2025 | GEN | Silver Anniversary of the Human Genome Project |
| 13 Jun. 2025 | GEN | Proteomics Partnerships Move Multiomics from Theory to Practice |
| 12 Jun. 2025 | Colorado State University | The pathogen hunter: Next-Generation Sequencing tracks down genetic mutations |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.